Retaglutide is a innovative GLP-1 receptor agonist currently under research for the management of type 2 diabetes. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://janedecc575604.slypage.com/39591995/trelaglutide-exploring-a-new-therapy-for-chronic-diseases